159 related articles for article (PubMed ID: 33809217)
61. Predictive factors of six-week mortality in critically ill patients with SARS-CoV-2: A multicenter prospective study.
Estella Á; Garcia Garmendia JL; de la Fuente C; Machado Casas JF; Yuste ME; Amaya Villar R; Estecha MA; Yaguez Mateos L; Cantón Bulnes ML; Loza A; Mora J; Fernández Ruiz L; Díez Del Corral Fernández B; Rojas Amezcua M; Rodriguez Higueras MI; Díaz Torres I; Recuerda Núñez M; Zaheri Beryanaki M; Rivera Espinar F; Matallana Zapata DF; Moreno Cano SG; Gimenez Beltrán B; Muñoz N; Sainz de Baranda Piñero A; Bustelo Bueno P; Moreno Barriga E; Rios Toro JJ; Pérez Ruiz M; Gómez González C; Breval Flores A; de San José Bermejo Gómez A; Ruiz Cabello Jimenez MA; Guerrero Marín M; Ortega Ordiales A; Tejero-Aranguren J; Rodriguez Mejías C; Gomez de Oña J; de la Hoz C; Ocaña Fernández D; Ibañez Cuadros S; Garnacho Montero J;
Med Intensiva (Engl Ed); 2021 Mar; 46(4):179-91. PubMed ID: 33812670
[TBL] [Abstract][Full Text] [Related]
62. Elevated Liver Enzymes, Ferritin, C-reactive Protein, D-dimer, and Age Are Predictive Markers of Outcomes Among African American and Hispanic Patients With Coronavirus Disease 2019.
Ashktorab H; Pizuorno A; Aduli F; Laiyemo AO; Oskrochi G; Brim H
Gastroenterology; 2021 Jul; 161(1):345-349. PubMed ID: 33811923
[No Abstract] [Full Text] [Related]
63. Serum IP-10 and IL-7 levels are associated with disease severity of coronavirus disease 2019.
Wang GL; Gao HX; Wang YL; Wei X; Liu YZ; Lu JH; Li L; Wang HB; Zhao L; Rong YX; Yao L; Duan LJ; Anderson BD; Ma MJ; Dai EH; Zhao XN
Cytokine; 2021 Jun; 142():155500. PubMed ID: 33810947
[TBL] [Abstract][Full Text] [Related]
64. Biomarkers of coagulation, endothelial function, and fibrinolysis in critically ill patients with COVID-19: A single-center prospective longitudinal study.
Juneja GK; Castelo M; Yeh CH; Cerroni SE; Hansen BE; Chessum JE; Abraham J; Cani E; Dwivedi DJ; Fraser DD; Slessarev M; Martin C; McGilvray S; Gross PL; Liaw PC; Weitz JI; Kim PY;
J Thromb Haemost; 2021 Jun; 19(6):1546-1557. PubMed ID: 33826233
[TBL] [Abstract][Full Text] [Related]
65. Pharmacokinetic and Pharmacodynamic Evaluation of Ravulizumab in Adults with Severe Coronavirus Disease 2019.
McEneny-King AC; Monteleone JPR; Kazani SD; Ortiz SR
Infect Dis Ther; 2021 Jun; 10(2):1045-1054. PubMed ID: 33826106
[TBL] [Abstract][Full Text] [Related]
66. CD169/SIGLEC1 is expressed on circulating monocytes in COVID-19 and expression levels are associated with disease severity.
Doehn JM; Tabeling C; Biesen R; Saccomanno J; Madlung E; Pappe E; Gabriel F; Kurth F; Meisel C; Corman VM; Hanitsch LG; Treskatsch S; Heim K; Stegemann MS; Ruwwe-Glösenkamp C; Müller-Redetzky HC; Uhrig A; Somasundaram R; Spies C; von Bernuth H; Hofmann J; Drosten C; Suttorp N; Witzenrath M; Sander LE; Hübner RH
Infection; 2021 Aug; 49(4):757-762. PubMed ID: 33825125
[TBL] [Abstract][Full Text] [Related]
67. The Effect of Chronic and Inhospital Exposure to Renin-Angiotensin System Inhibitors on the Outcome and Inflammatory State of Coronavirus Disease 2019 Adult Inpatients.
Gaspar P; Parreira I; Antunes Meireles P; Bessa F; Dias Silva V; Abrantes AM; Pais de Lacerda A; Mota C
Int J Hypertens; 2021; 2021():5517441. PubMed ID: 33824762
[TBL] [Abstract][Full Text] [Related]
68. T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses.
Ogbe A; Kronsteiner B; Skelly DT; Pace M; Brown A; Adland E; Adair K; Akhter HD; Ali M; Ali SE; Angyal A; Ansari MA; Arancibia-Cárcamo CV; Brown H; Chinnakannan S; Conlon C; de Lara C; de Silva T; Dold C; Dong T; Donnison T; Eyre D; Flaxman A; Fletcher H; Gardner J; Grist JT; Hackstein CP; Jaruthamsophon K; Jeffery K; Lambe T; Lee L; Li W; Lim N; Matthews PC; Mentzer AJ; Moore SC; Naisbitt DJ; Ogese M; Ogg G; Openshaw P; Pirmohamed M; Pollard AJ; Ramamurthy N; Rongkard P; Rowland-Jones S; Sampson O; Screaton G; Sette A; Stafford L; Thompson C; Thomson PJ; Thwaites R; Vieira V; Weiskopf D; Zacharopoulou P; ; ; Turtle L; Klenerman P; Goulder P; Frater J; Barnes E; Dunachie S
Nat Commun; 2021 Apr; 12(1):2055. PubMed ID: 33824342
[TBL] [Abstract][Full Text] [Related]
69. Prone position in intubated, mechanically ventilated patients with COVID-19: a multi-centric study of more than 1000 patients.
Langer T; Brioni M; Guzzardella A; Carlesso E; Cabrini L; Castelli G; Dalla Corte F; De Robertis E; Favarato M; Forastieri A; Forlini C; Girardis M; Grieco DL; Mirabella L; Noseda V; Previtali P; Protti A; Rona R; Tardini F; Tonetti T; Zannoni F; Antonelli M; Foti G; Ranieri M; Pesenti A; Fumagalli R; Grasselli G;
Crit Care; 2021 Apr; 25(1):128. PubMed ID: 33823862
[TBL] [Abstract][Full Text] [Related]
70. Persisting olfactory dysfunction improves in patients 6 months after COVID-19 disease.
Otte MS; Bork ML; Zimmermann PH; Klussmann JP; Luers JC
Acta Otolaryngol; 2021 Jun; 141(6):626-629. PubMed ID: 33823752
[TBL] [Abstract][Full Text] [Related]
71. Extracorporeal Membrane Oxygenation in Patients With COVID-19: An International Multicenter Cohort Study.
Raasveld SJ; Delnoij TSR; Broman LM; Lansink-Hartgring AO; Hermans G; De Troy E; Taccone FS; Diaz MQ; der Velde FV; Miranda DDR; Scholten E; ; Vlaar APJ
J Intensive Care Med; 2021 Aug; 36(8):910-917. PubMed ID: 33823709
[TBL] [Abstract][Full Text] [Related]
72. Impact of the vitamin D deficiency on COVID-19 infection and mortality in Asian countries.
Jayawardena R; Jeyakumar DT; Francis TV; Misra A
Diabetes Metab Syndr; 2021; 15(3):757-764. PubMed ID: 33823331
[TBL] [Abstract][Full Text] [Related]
73. Inflammatory Profiles and Clinical Features of Coronavirus 2019 Survivors 3 Months After Discharge in Wuhan, China.
Zhou M; Yin Z; Xu J; Wang S; Liao T; Wang K; Li Y; Yang F; Wang Z; Yang G; Zhang J; Jin Y
J Infect Dis; 2021 Nov; 224(9):1473-1488. PubMed ID: 33822106
[TBL] [Abstract][Full Text] [Related]
74. A CD14 Polymorphism (C-159T rs2569190) Is Associated With SARS-CoV-2 Infection and Mortality in the European Population.
Pati A; Padhi S; Panda D; Suvankar S; Panda AK
J Infect Dis; 2021 Sep; 224(5):921-922. PubMed ID: 33822099
[No Abstract] [Full Text] [Related]
75. Development of COVIDVax Model to Estimate the Risk of SARS-CoV-2-Related Death Among 7.6 Million US Veterans for Use in Vaccination Prioritization.
Ioannou GN; Green P; Fan VS; Dominitz JA; O'Hare AM; Backus LI; Locke E; Eastment MC; Osborne TF; Ioannou NG; Berry K
JAMA Netw Open; 2021 Apr; 4(4):e214347. PubMed ID: 33822066
[TBL] [Abstract][Full Text] [Related]
76. Hyperinflammation as underlying mechanism predisposing patients with cardiovascular diseases for severe COVID-19.
Landmesser U; Lehmann I; Eils R
Eur Heart J; 2021 May; 42(18):1720-1721. PubMed ID: 33822037
[No Abstract] [Full Text] [Related]
77. Multisystem Inflammatory Syndrome in Adults after Mild SARS-CoV-2 Infection, Japan.
Yamada Y; Fujinami K; Eguchi T; Takefuji H; Mori N
Emerg Infect Dis; 2021 Jun; 27(6):1740-1742. PubMed ID: 33821784
[TBL] [Abstract][Full Text] [Related]
78. Alterations in T and B cell function persist in convalescent COVID-19 patients.
Shuwa HA; Shaw TN; Knight SB; Wemyss K; McClure FA; Pearmain L; Prise I; Jagger C; Morgan DJ; Khan S; Brand O; Mann ER; Ustianowski A; Bakerly ND; Dark P; Brightling CE; Brij S; ; Felton T; Simpson A; Grainger JR; Hussell T; Konkel JE; Menon M
Med; 2021 Jun; 2(6):720-735.e4. PubMed ID: 33821250
[TBL] [Abstract][Full Text] [Related]
79. Cardiac magnetic resonance findings in coronavirus disease 2019.
Rezaeian N; Hosseini L; Asadian S
Clin Case Rep; 2021 Apr; 9(4):2168-2173. PubMed ID: 33821185
[TBL] [Abstract][Full Text] [Related]
80. Clinical features and predictors of severity in COVID-19 patients with critical illness in Singapore.
Puah SH; Young BE; Chia PY; Ho VK; Loh J; Gokhale RS; Tan SY; Sewa DW; Kalimuddin S; Tan CK; Pada SKMS; Cove ME; Chai LYA; Parthasarathy P; Ho BCH; Ng JJ; Ling LM; Abisheganaden JA; Lee VJM; Tan CH; Lin RTP; Leo YS; Lye DC; Yeo TW;
Sci Rep; 2021 Apr; 11(1):7477. PubMed ID: 33820944
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
